GCP Could Lengthen Life Expectancy Of Prostate Cancer Patients
2/23/2013
The life expectancy of some prostate cancer patients could be lengthened with a natural, non-toxic substance called genistein-combined polysaccharide (GCP). The finding came from a new study on prostate cancer cells and mice conducted by researchers from University of California, Davis, and was published in Endocrine-Related Cancer...
Over Two Thirds Of Sunbed Users Concerned They Are Aging Their Skin
2/23/2013
Results of a survey by the charity Cancer Research UK show that more than two thirds (68%) of people who use sunbeds are concerned that the practice is aging their skin. The research, which polled 2,500 UK adults in January, was released to coincide with the charity's R UV UGLY sunbed awareness campaign...
Kadcyla For Late-Stage Breast Cancer Approved By FDA
2/22/2013
Kadcyla (ado-trastuzumab emtansine), a new medication for the treatment of HER2-positive, metastatic breast cancer, has been approved by the Food and Drug Administration (FDA), USA. Metastatic, also known as late-stage, means the cancer has spread to other parts of the body...
Kadcyla For Late-Stage Breast Cancer Approved By FDA
2/22/2013
Kadcyla (ado-trastuzumab emtansine), a new medication for the treatment of HER2-positive, metastatic breast cancer, has been approved by the Food and Drug Administration (FDA), USA. Metastatic, also known as late-stage, means the cancer has spread to other parts of the body...
Astronomy Algorithms Help Diagnose Aggressive Tumors
2/22/2013
In a remarkable example of interdisciplinary teamwork, astronomers are helping cancer researchers use computerized stargazing algorithms developed for spotting distant galaxies to identify biomarkers in tumors to determine how aggressive they are...
Astronomy Algorithms Help Diagnose Aggressive Tumors
2/22/2013
In a remarkable example of interdisciplinary teamwork, astronomers are helping cancer researchers use computerized stargazing algorithms developed for spotting distant galaxies to identify biomarkers in tumors to determine how aggressive they are...
Treatment with bendamustine plus rituximab (B-R) doubles progression free survival (PFS) compared with current standard of care CHOP-R (69.5 versus 31...
Treatment with bendamustine plus rituximab (B-R) doubles progression free survival (PFS) compared with current standard of care CHOP-R (69.5 versus 31...
For Colorectal Cancer Prevention, Resistant Starch Should Be On The Menu
2/22/2013
As the name suggests, you can't digest resistant starch so it ends up in the bowel in pretty much the same form it entered your mouth. As unlovely as that seems, once in the bowel this resistant starch does some important things, including decreasing bowel pH and transit time, and increasing the production of short-chain fatty acids...
Promising New Compound For Battling Kidney Cancer
2/22/2013
Chemists at the University of California, Riverside have developed a compound that holds much promise in the laboratory in fighting renal (kidney) cancer...